Clinical Trial Update: The FAVOR II China Study

View source ↗

Summary

This document reports the completion of the FAVOR II China clinical trial sponsored by the China National Center for Cardiovascular Diseases, studying condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Artery Disease, Myocardial Ischemia | Status: COMPLETED